Related Experiment Video
Updated: Dec 27, 2025

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management
Published on: November 30, 2022
The 'Expiry Problem' of broad consent for biobank research - And why a meta consent model solves it
Thomas Ploug1, Søren Holm2,3
1Centre for Applied Ethics and Philosophy of Science, Department of Communication and Psychology, Aalborg University Copenhagen, København S, Denmark ploug@hum.aau.dk.
Abstract:
In this response to Neil Manson's latest intervention in our debate about the best consent model for biobank research we show, contra Manson that the 'expiry problem' that affects broad consent models because of changes over time in methods, purposes, types of data used and governance structures is a real and significant problem. We further show that our preferred implementation of meta consent as a national consent platform solves this problem and is not subject to the cost and burden objections that Manson raises.
Related Concept Videos
Ethics in Research
Bioequivalence studies: Biowaivers
Bioavailability Study Design: Healthy Subjects Versus Patients
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Bioequivalence: Overview
Mechanistic Models: Compartment Models in Individual and Population Analysis

